Silexion Therapeutics (SLXNW) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-7.4
-5.19
-2.98
-0.77

Details

Expected EPS
-3.15
Actual EPS
-4.32
Surprise EPS
-1.17
Surprise Percent
+37.14%

Description

Silexion Therapeutics (SLXNW) has reported earnings of -4.32 per share for Q3 2025.

0 Comments

Share your thoughts